Becton Dickinson and Company (NYSE:BDX) went up by 3.09% from its latest closing price compared to the recent 1-year high of $277.29. The company’s stock price has collected 3.53% of gains in the last five trading sessions. The Wall Street Journal reported on 09/15/20 that Covid-19 Test Maker Examines False-Positive Results in Nursing Homes
Is It Worth Investing in Becton Dickinson and Company (NYSE :BDX) Right Now?
Becton Dickinson and Company (NYSE:BDX) scored a price-to-earnings ratio above its average ratio, recording 39.82 x from its present earnings ratio. Plus, the 36-month beta value for BDX is at 0.60. Opinions of the stock are interesting as 8 analysts out of 17 who provided ratings for Becton Dickinson and Company declared the stock was a “buy,” while 1 rated the stock as “overweight,” 7 rated it as “hold,” and 1 as “sell.”
The average price from analysts is $270.45, which is $20.67 above the current price. BDX currently public float of 282.74M and currently shorts hold a 1.24% ratio of that float. Today, the average trading volume of BDX was 1.05M shares.
BDX’s Market Performance
BDX stocks went up by 3.53% for the week, with a monthly jump of 2.53% and a quarterly performance of -0.41%, while its annual performance rate touched 1.67%. The volatility ratio for the week stands at 1.98% while the volatility levels for the past 30 days are set at 1.73% for Becton Dickinson and Company. The simple moving average for the period of the last 20 days is 4.63% for BDX stocks with a simple moving average of 0.99% for the last 200 days.
Analysts’ Opinion of BDX
Many brokerage firms have already submitted their reports for BDX stocks, with Citigroup repeating the rating for BDX by listing it as a “Sell.” The predicted price for BDX in the upcoming period, according to Citigroup is $235 based on the research report published on July 11th of the current year 2022.
Wells Fargo, on the other hand, stated in their research note that they expect to see BDX reach a price target of $275. The rating they have provided for BDX stocks is “Overweight” according to the report published on June 24th, 2022.
BDX Trading at 2.87% from the 50-Day Moving Average
After a stumble in the market that brought BDX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -8.94% of loss for the given period.
Volatility was left at 1.73%, however, over the last 30 days, the volatility rate increased by 1.98%, as shares surge +2.48% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -1.75% lower at present.
During the last 5 trading sessions, BDX rose by +3.53%, which changed the moving average for the period of 200-days by +5.90% in comparison to the 20-day moving average, which settled at $241.64. In addition, Becton Dickinson and Company saw 2.99% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at BDX starting from Spoerel Thomas J, who sale 443 shares at the price of $260.00 back on Jun 07. After this action, Spoerel Thomas J now owns 1,058 shares of Becton Dickinson and Company, valued at $115,180 using the latest closing price.
Hickey David, the EVP & President, Life Sciences of Becton Dickinson and Company, sale 475 shares at $256.00 during a trade that took place back on May 06, which means that Hickey David is holding 3,806 shares at $121,600 based on the most recent closing price.
Stock Fundamentals for BDX
Current profitability levels for the company are sitting at:
- +16.15 for the present operating margin
- +46.80 for the gross margin
The net margin for Becton Dickinson and Company stands at +10.33. The total capital return value is set at 7.80, while invested capital returns managed to touch 5.10. Equity return is now at value 7.60, with 3.40 for asset returns.
Based on Becton Dickinson and Company (BDX), the company’s capital structure generated 74.38 points at debt to equity in total, while total debt to capital is 42.65. Total debt to assets is 33.56, with long-term debt to equity ratio resting at 72.26. Finally, the long-term debt to capital ratio is 41.44.
When we switch over and look at the enterprise to sales, we see a ratio of 4.26, with the company’s debt to enterprise value settled at 0.20. The receivables turnover for the company is 8.27 and the total asset turnover is 0.38. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.33.